Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Rescue Plan Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2022 · third_quarter · Q3
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to technical expertise in sealing device technology and emissions reductions. Issues related to hydrogen technology and development. Issues related to Federal Helium Program.
Source: Senate LDA
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
American Rescue Plan Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
PFAS Action Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to technical expertise in sealing device technology and emissions reductions. Issues related to hydrogen technology and development. Issues related to Federal Helium Program.
PFAS Action Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to technical expertise in sealing device technology and emissions reductions. Issues related to hydrogen technology and development.
PFAS Action Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to technical expertise in sealing device technology and emissions reductions. Issues related to hydrogen technology and development.
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236); FY2023 National Defense Authorization Act (H.R.7900).
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (P.L.117-81); FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); FY2023 Department of Defense Appropriations; FY2023 National Defense Authorization Act.
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); FY2023 National Defense Authorization Act (H.R.7900, S.4543).
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Consolidated Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
NOPAIN Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
NOPAIN Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
NOPAIN Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Department of Homeland Security Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Department of Defense Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Department of Defense Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (P.L.117-81); FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); FY2023 Department of Defense Appropriations; FY2023 National Defense Authorization Act.
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
National Defense Authorization Act for Fiscal Year 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
National Defense Authorization Act for Fiscal Year 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236); FY2023 National Defense Authorization Act (H.R.7900).
National Defense Authorization Act for Fiscal Year 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); FY2023 National Defense Authorization Act (H.R.7900, S.4543).
National Defense Authorization Act for Fiscal Year 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Department of Defense Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236); FY2023 National Defense Authorization Act (H.R.7900).
Department of Defense Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); FY2023 National Defense Authorization Act (H.R.7900, S.4543).
Department of Defense Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Department of Defense Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Department of Homeland Security Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Department of Homeland Security Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
A bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2022, and for other purposes.
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
A bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2022, and for other purposes.
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (P.L.117-81); FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); FY2023 Department of Defense Appropriations; FY2023 National Defense Authorization Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Department of Homeland Security Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); FY2023 National Defense Authorization Act (H.R.7900, S.4543).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Department of Defense Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Department of Defense Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); FY2023 National Defense Authorization Act (H.R.7900, S.4543).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Department of Homeland Security Appropriations Act, 2023
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
Consolidated Appropriations Act, 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Consolidated Appropriations Act, 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Consolidated Appropriations Act, 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
CARES Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
CARES Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
CARES Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
CARES Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
CARES Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
CARES Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
American Rescue Plan Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
American Rescue Plan Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
American Rescue Plan Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
American Rescue Plan Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
PFAS Action Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
PFAS Action Act of 2021
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021, FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
NOPAIN Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
NOPAIN Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
NOPAIN Act
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021, FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432); FY2022 National Defense Authorization Act (H.R.4350/S.2792).
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81).
Department of Homeland Security Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Department of Homeland Security Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Department of Defense Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Department of Defense Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Department of Defense Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81).
Department of Defense Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432); FY2022 National Defense Authorization Act (H.R.4350/S.2792).
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81).
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021, FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432); FY2022 National Defense Authorization Act (H.R.4350/S.2792).
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81).
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021, FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
National Defense Authorization Act for Fiscal Year 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
A bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2022, and for other purposes.
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
A bill making appropriations for the Department of Defense for the fiscal year ending September 30, 2022, and for other purposes.
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Department of Homeland Security Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022
Client: SMITHS GROUP SERVICES CORPORATION · Firm: SMITHS GROUP SERVICES CORPORATION
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.586, NOPAIN Act; S.987, CARA 3.0 Act of 2021.
Issues related to U.S. Department of Veteran Affairs contracting practices.
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); FY2023 National Defense Authorization Act (H.R.7900, S.4543).
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257, S.4678); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900, S.4543); FY2023 Department of Defense Appropriations Act (H.R.8236, S.4663); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256, S.4664); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); Reimbursement for Medical Devices.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, Veterans Affairs, Dept of (VA), White House Office
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2022 · second_quarter · Q2
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation; FY2023 Department of Defense Appropriations Act (H.R.8236); FY2023 National Defense Authorization Act (H.R.7900).
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Funding for aviation security and homeland security technologies. Funding for Chemical, Biological, Radiological, Nuclear and Explosive technologies. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. H.R.2471, Consolidated Appropriations Act, 2022 (P.L.117-103) implementation. FY2023 Department of Homeland Security Appropriations Act (H.R.8257); Transportation Security Administration (TSA) funding. FY2023 National Defense Authorization Act (H.R.7900); FY2023 Department of Defense Appropriations Act (H.R.8236); Chemical Bio Funding; Navy RDT&E and Ship Equipment. FY2023 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.8256); Opioid Funding. FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295); Reimbursement for Medical Devices.
Issues related to U.S. Department of Veteran Affairs contracting practices.
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to technical expertise in sealing device technology and emissions reductions. Issues related to hydrogen technology and development.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, Veterans Affairs, Dept of (VA), White House Office
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2022 · first_quarter · Q1
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (P.L.117-81); FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); FY2023 Department of Defense Appropriations; FY2023 National Defense Authorization Act.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to technical expertise in sealing device technology and emissions reductions. Issues related to hydrogen technology and development.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136) implementation; S.586/H.R.3259, NOPAIN Act; Comprehensive Addiction and Recovery Act (CARA) programs; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); FY2023 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2023 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); FY2023 Commerce, Justice, Science, and Related Agencies Appropriations; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (P.L.117-81); FY2023 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation. FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103).
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, White House Office
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2021 · fourth_quarter · Q4
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81).
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021, FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431, S.3058); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432, S.3023); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505, S.3042); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502, S.3062); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350, S.2792, S.1605, P.L.117-81). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, Nuclear Regulatory Commission (NRC), SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, White House Office
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2021 · third_quarter · Q3
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act (H.R.4432); FY2022 National Defense Authorization Act (H.R.4350/S.2792).
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS; H.R.2467, PFAS Action Act of 2021. Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act (H.R.4431); Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act (H.R.4432); Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.4505); Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502); Reimbursement for Medical Devices. FY2022 National Defense Authorization Act (H.R.4350/S.2792). H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, White House Office
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2021 · second_quarter · Q2
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS. Issues related to hydro power and nuclear power. General discussions regarding technical expertise in sealing device technology and emissions reductions.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2021 · first_quarter · Q1
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.586, NOPAIN Act; S.987, CARA 3.0 Act of 2021.
Funding for aviation security and homeland security technologies. FY2022 Department of Homeland Security Appropriations Act; Transportation Security Administration (TSA) funding. FY2022 Department of Defense Appropriations Act; Chemical Bio Funding; Navy RDT&E. FY2022 Commerce, Justice, Science, and Related Agencies Appropriations Act; Opioid Funding. FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Reimbursement for Medical Devices. FY2022 National Defense Authorization Act. H.R.748, CARES Act (P.L.116-136) implementation. H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation. H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2020 · fourth_quarter · Q4
General issues related to tort reform and minimal diversity jurisdiction. Civil liability issues in possible COVID related legislation.
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2021 Department of Defense Appropriations Act (H.R.7617/Senate) and FY2021 National Defense Authorization Act (H.R.6395/S.4049).
Issues related to patient infusion therapy, Medicare reimbursements for tracheotomy tubes, reimbursement/policy issues related to opioid alternative treatments, medical device technology related to the opioid epidemic and the COVID-19 pandemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. H.R.5172/S.3067, NOPAIN Act. Federal COVID response, including Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L.116-136).
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2020 · third_quarter · Q3
Issues related to patient infusion therapy, Medicare reimbursements for tracheotomy tubes, reimbursement/policy issues related to opioid alternative treatments, medical device technology related to the opioid epidemic and the COVID-19 pandemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. H.R.5172/S.3067, NOPAIN Act. Federal COVID response, including Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L.116-136).
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2020 · second_quarter · Q2
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Funding for aviation security and homeland security technologies. H.R.1171, Funding for Aviation Screeners and Threat Elimination Restoration Act (FASTER Act); aviation security fees. Monitored applicable FY20 appropriations bills. FY21 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY21 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY21 Commerce, Justice, Science Appropriations; Opioid Funding. FY21 Departments of Labor, Health and Human Services, and Education Appropriations; Reimbursement for Medical Devices.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2020 · first_quarter · Q1
General discussions related to corporate tax policies and regulations.
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY20/FY21 National Defense Authorization and FY20/FY21 Department of Defense Appropriations.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2019 · fourth_quarter · Q4
Issues related to climate change and emissions technologies. Issues related to PFAS; S.1790/H.R.2500, National Defense Authorization Act for Fiscal Year 2020 (P.L.116-92); S.1507, PFAS Release Disclosure Act. Issues related to mechanical seals emissions technologies and energy infrastructure.
Funding for aviation security and homeland security technologies. H.R.1171, Funding for Aviation Screeners and Threat Elimination Restoration Act (FASTER Act); aviation security fees. Monitored applicable FY19 appropriations bills. H.R.3931/S.2582, Department of Homeland Security Appropriations Act, 2020; Transportation Security Administration (TSA) funding. H.R.2968/S.2474, Department of Defense Appropriations Act, 2020; Chemical Bio Funding. H.R.3055/S.2584, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020; Opioid Funding. H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020; Reimbursement for Medical Devices. H.R.2740, the FY2020 Consolidated measure; H.R.3055, the FY2020 Consolidated measure; H.R.1158, Consolidated Appropriations Act, 2020 (P.L.116-93); H.R.1865, Further Consolidated Appropriations Act, 2020 (P.L.116-94).
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2019 · first_quarter · 1A
Tax issues affecting the industry, including repeal of the medical device excise tax; S.692, Protect Medical Innovation Act of 2019.
Reimbursement and policy issues related to non-opioid acute pain management.
Issues related to the United States-Mexico-Canada Agreement (USMCA). Issues related to Section 301 and Section 232 tariffs.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2019 · second_quarter · 2A
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (USMCA).
Issues related to climate change and emissions technologies. Issues related to PFAS; S.1790/H.R.2500, National Defense Authorization Act for Fiscal Year 2020; S.1507, PFAS Release Disclosure Act. Issues related to mechanical seals emissions technologies and energy infrastructure.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2019 · third_quarter · Q3
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.692/H.R.2207, Protect Medical Innovation Act of 2019.
Issues related to climate change and emissions technologies. Issues related to PFAS; S.1790/H.R.2500, National Defense Authorization Act for Fiscal Year 2020; S.1507, PFAS Release Disclosure Act. Issues related to mechanical seals emissions technologies and energy infrastructure.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2019 · second_quarter · Q2
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.692/H.R.2207, Protect Medical Innovation Act of 2019.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (USMCA).
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2019 · first_quarter · Q1
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.692, Protect Medical Innovation Act of 2019.
Issues related to the United States-Mexico-Canada Agreement (USMCA). Issues related to Section 301 and Section 232 tariffs.
Reimbursement and policy issues related to non-opioid acute pain management.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2018 · fourth_quarter · Q4
Tax issues affecting the industry, including repeal of the medical device excise tax. H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.88, Retirement, Savings, and Other Tax Relief Act of 2018 and Taxpayer First Act of 2018.
Issues related to climate change and emissions technologies.
Issues related to the United States-Mexico-Canada Agreement (USMCA). Issues related to Section 301 and Section 232 tariffs.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2018 · third_quarter · Q3
Issues related to tort reform. H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017. H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017. H.R.3487, To amend section 1332 of title 28, United States Code, to provide that the requirement for diversity of citizenship jurisdiction is met if any one party to the case is diverse in citizenship from any one adverse party in the case. S.3249, Federal Courts Access Act of 2018.
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. Implementation of H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2018 · second_quarter · Q2
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.
Reimbursement and policy issues related to non-opioid acute pain management. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2018 · first_quarter · Q1
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures: FY18 Defense and FY18 DHS Appropriations in H.R.1370, Further Additional Continuing Appropriations Act, 2018 (P.L.115-96), H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120), H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123), H.R.1625, Consolidated Appropriations Act, 2018 (P.L.115-141). FY19 DHS Appropriations, Transportation Security Administration (TSA) funding; FY19 Defense Appropriations, Chemical Biological Funding; FY19 Commerce, Justice, Science Appropriations, Opioid Funding; FY19 Labor HHS Bill, Reimbursement for Medical Devices. Support DoD and DOE funding in FY19 for Columbia Class ballistic missile submarine development. Support DoD funding request for Virginia Class submarine construction, Virginia Class submarines, and submarine upgrades in FY19. Request additional funding to FY19 Navy SCN, Columbia Class Submarine Advance Procurement Funding for Supplier Base Reconstitution.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2017 · fourth_quarter · 4A
Issues related to climate change and emissions technologies.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; H.R.1, Tax Cuts and Jobs Act (P.L.115-97); Issues related to the repeal of the medical device excise tax; tax reform; international tax issues; manufacturing and taxes.
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2017 · third_quarter · 3A
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.2430/S.934, FDA Reauthorization Act of 2017 (P.L.115-52); regulations related to Medical Device User Fee Amendments (MDUFA). H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2017 · fourth_quarter · Q4
Issues related to climate change and emissions technologies.
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2017 · third_quarter · Q3
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.2430/S.934, FDA Reauthorization Act of 2017 (P.L.115-52); regulations related to Medical Device User Fee Amendments (MDUFA). H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2017 · second_quarter · Q2
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2017 · first_quarter · Q1
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; issues related to tort reform.
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP) and the Domestic Nuclear Detection Office (DNDO). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. Issues related to implementation of First Responder Network Authority (FirstNet).
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2016 · fourth_quarter · Q4
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP) and the Domestic Nuclear Detection Office (DNDO). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. Issues related to implementation of First Responder Network Authority (FirstNet).
Issues related to climate change and emissions technologies.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2016 · third_quarter · Q3
H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP) and the Domestic Nuclear Detection Office (DNDO). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. Issues related to implementation of First Responder Network Authority (FirstNet).
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2016 · second_quarter · Q2
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
SMITHS GROUP SERVICES CORPORATION via SMITHS GROUP SERVICES CORPORATION
2016 · first_quarter · Q1
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
Issues related to climate change and emissions technologies.
Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act; FY2022 National Defense Authorization Act.
Filing targets: Army, Dept of (Other), Bureau of Reclamation, Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, White House Office
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS. Issues related to hydro power and nuclear power.
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2022 Department of Defense Appropriations Act; FY2022 National Defense Authorization Act.
Filing targets: Army, Dept of (Other), Bureau of Reclamation, Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, White House Office
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS. Issues related to hydro power.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (P.L.116-113).
Funding for aviation security and homeland security technologies. H.R.1171, Funding for Aviation Screeners and Threat Elimination Restoration Act (FASTER Act); aviation security fees. Monitored applicable FY2020 appropriations bills. FY2021 Department of Homeland Security Appropriations Act (H.R.7669/Senate); Transportation Security Administration (TSA) funding. FY2021 Department of Defense Appropriations Act (H.R.7617/Senate); Chemical Bio Funding; Navy RDT&E. FY2021 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.7667/Senate); Opioid Funding. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614/Senate); Reimbursement for Medical Devices. H.R.7617, FY2021 Consolidated Appropriations Act. FY2021 National Defense Authorization Act (H.R.6395/S.4049). H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions Act, HEROES Act. The Health, Economic Assistance, Liability Protection and Schools Act, HEALS Act (Senate proposed legislation). H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
General issues related to tort reform and minimal diversity jurisdiction. Civil liability issues in possible COVID related legislation.
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS.
Funding for aviation security and homeland security technologies. H.R.1171, Funding for Aviation Screeners and Threat Elimination Restoration Act (FASTER Act); aviation security fees. Monitored applicable FY2020 appropriations bills. FY2021 Department of Homeland Security Appropriations Act (H.R.7669/Senate); Transportation Security Administration (TSA) funding. FY2021 Department of Defense Appropriations Act (H.R.7617/Senate); Chemical Bio Funding; Navy RDT&E. FY2021 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.7667/Senate); Opioid Funding. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614/Senate); Reimbursement for Medical Devices. H.R.7617, FY2021 Consolidated Appropriations Act. FY2021 National Defense Authorization Act (H.R.6395/S.4049). H.R.6800, Health and Economic Recovery Omnibus Emergency Solutions Act, HEROES Act. The Health, Economic Assistance, Liability Protection and Schools Act, HEALS Act (Senate proposed legislation).
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; FY2021 Department of Defense Appropriations Act (H.R.7617/Senate) and FY2021 National Defense Authorization Act (H.R.6395/S.4049).
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Navy RDT&E and Ship Equipment; H.R.6395/S.4049, National Defense Authorization Act for Fiscal Year 2021 and FY20/FY21 Department of Defense Appropriations.
General issues related to tort reform and minimal diversity jurisdiction. Civil liability issues in possible COVID related legislation.
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure. Issues related to PFAS.
Issues related to patient infusion therapy, Medicare reimbursements for tracheotomy tubes, reimbursement/policy issues related to opioid alternative treatments, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. H.R.5172/S.3067, NOPAIN Act. Federal COVID response, including Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L.116-136).
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Navy, Dept of, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
Funding for aviation security and homeland security technologies. H.R.1171, Funding for Aviation Screeners and Threat Elimination Restoration Act (FASTER Act); aviation security fees. Monitored applicable FY20 appropriations bills. FY21 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. FY21 Department of Defense Appropriations; Chemical Bio Funding; Navy RDT&E. FY21 Commerce, Justice, Science Appropriations; Opioid Funding. FY21 Departments of Labor, Health and Human Services, and Education Appropriations; Reimbursement for Medical Devices.
Issues related to climate change and emissions technologies. Issues related to mechanical seals emissions technologies and energy infrastructure.
Issues related to patient infusion therapy, Medicare reimbursements for tracheotomy tubes, reimbursement/policy issues related to opioid alternative treatments, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. H.R.5172/S.3067, NOPAIN Act. Federal COVID response, including Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L.116-136).
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (USMCA); H.R.5430, United States-Mexico-Canada Agreement Implementation Act (P.L.116-113).
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Navy, Dept of, Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (USMCA); H.R.5430, United States-Mexico-Canada Agreement Implementation Act.
Tax issues affecting the industry, including repeal of the medical device excise tax; S.692/H.R.2207, Protect Medical Innovation Act of 2019; H.R.1865, Further Consolidated Appropriations Act, 2020 (P.L.116-94).
Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology, detection solutions for the Department of Defense, and Naval ship equipment; FY19 National Defense Authorization and FY19 Department of Defense Appropriations; S.1790/H.R.2500, National Defense Authorization Act for Fiscal Year 2020 (P.L.116-92); H.R.2968/S.2474, Department of Defense Appropriations Act, 2020; H.R.2740, the FY2020 Consolidated measure; H.R.1158, Consolidated Appropriations Act, 2020 (P.L.116-93).
Issues related to patient infusion therapy, Medicare reimbursements for tracheotomy tubes, reimbursement/policy issues related to opioid alternative treatments, and medical device technology related to the opioid epidemic; Implementation of the 21st Century Cures Act (P.L.114-255); Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act; H.R.5172/S.3067, NOPAIN Act.
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Navy, Dept of, Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.692, Protect Medical Innovation Act of 2019.
Issues related to climate change and emissions technologies.
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. H.J.Res.31, Consolidated Appropriations Act, 2019 (P.L.116-6). FY20 Department of Homeland Security Appropriations, Transportation Security Administration (TSA) funding. FY20 Department of Defense Appropriations, Chemical Biological Funding. FY20 Commerce, Justice, Science, and Related Agencies Appropriations, Opioid Funding. FY20 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, Reimbursement for Medical Devices.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. FY20 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. H.R.2968, Department of Defense Appropriations Act, 2020; Chemical Biological Funding. H.R.3055, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020; Opioid Funding. H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020; Reimbursement for Medical Devices. H.R.2740, the FY2020 Consolidated measure and H.R.3055, the FY2020 Consolidated measure.
Tax issues affecting the industry, including repeal of the medical device excise tax; S.692/H.R.2207, Protect Medical Innovation Act of 2019.
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of the 21st Century Cures Act (P.L.114-255). Implementation of Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.692/H.R.2207, Protect Medical Innovation Act of 2019.
Reimbursement and policy issues related to opioid alternative treatments.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. H.R.3931/S.2582, Department of Homeland Security Appropriations Act, 2020; Transportation Security Administration (TSA) funding. H.R.2968/S.2474, Department of Defense Appropriations Act, 2020; Chemical Biological Funding. H.R.3055/S.2584, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020; Opioid Funding. H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020; Reimbursement for Medical Devices. H.R.2740, the FY2020 Consolidated measure and H.R.3055, the FY2020 Consolidated measure.
Reimbursement and policy issues related to opioid alternative treatments.
General trade discussions including Section 301 and Section 232 tariffs. Issues related to the United States-Mexico-Canada Agreement (USMCA).
Tax issues affecting the industry, including repeal of the medical device excise tax; S.692/H.R.2207, Protect Medical Innovation Act of 2019.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
Tax issues affecting the industry, including repeal of the medical device excise tax; S.692/H.R.2207, Protect Medical Innovation Act of 2019.
Issues related to climate change and emissions technologies. Issues related to PFAS; S.1790/H.R.2500, National Defense Authorization Act for Fiscal Year 2020; S.1507, PFAS Release Disclosure Act. Issues related to mechanical seals emissions technologies and energy infrastructure.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. FY20 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding. H.R.2968, Department of Defense Appropriations Act, 2020; Chemical Biological Funding. H.R.3055, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020; Opioid Funding. H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020; Reimbursement for Medical Devices. H.R.2740, the FY2020 Consolidated measure and H.R.3055, the FY2020 Consolidated measure.
Reimbursement and policy issues related to opioid alternative treatments.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Tax issues affecting the industry, including repeal of the medical device excise tax; S.692, Protect Medical Innovation Act of 2019.
Issues related to climate change and emissions technologies.
Issues related to tort reform. Issues related to minimal diversity jurisdiction. S.297, Federal Courts Access Act of 2019.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. H.J.Res.31, Consolidated Appropriations Act, 2019 (P.L.116-6). FY20 Department of Homeland Security Appropriations, Transportation Security Administration (TSA) funding. FY20 Department of Defense Appropriations, Chemical Biological Funding. FY20 Commerce, Justice, Science, and Related Agencies Appropriations, Opioid Funding. FY20 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, Reimbursement for Medical Devices.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Reimbursement and policy issues related to non-opioid acute pain management.
Issues related to patient infusion therapy, medical device tax, Medicare reimbursements for tracheotomy tubes, and medical device technology related to the opioid epidemic. Implementation of 21st Century Cures Act (P.L.114-255). S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. Implementation of H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. S.3109/H.R.6776, Department of Homeland Security Appropriations Act, 2019, Transportation Security Administration (TSA) funding. H.R.6157/S.3159, Department of Defense Appropriations Act, 2019, Chemical Biological Funding. H.R.5952/S.3072, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019, Opioid Funding. S.3158/H.R.6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019, Reimbursement for Medical Devices. H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245). Monitored: H.R.3355, Department of Homeland Security Appropriations Act, FY2018, Transportation Security Administration (TSA) funding. H.R.3219, Department of Defense Appropriations Act, FY2018, Chemical and biological counter measures.
Issues related to tort reform. H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017. H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017. H.R.3487, To amend section 1332 of title 28, United States Code, to provide that the requirement for diversity of citizenship jurisdiction is met if any one party to the case is diverse in citizenship from any one adverse party in the case. S.3249, Federal Courts Access Act of 2018.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Reimbursement and policy issues related to non-opioid acute pain management.
Tax issues affecting the industry, including repeal of the medical device excise tax. H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. S.3109/H.R.6776, Department of Homeland Security Appropriations Act, 2019, Transportation Security Administration (TSA) funding. H.R.6157/S.3159, Department of Defense Appropriations Act, 2019, Chemical Biological Funding. H.R.5952/S.3072, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019, Opioid Funding. S.3158/H.R.6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019, Reimbursement for Medical Devices. H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245). Monitored: H.R.3355, Department of Homeland Security Appropriations Act, FY2018, Transportation Security Administration (TSA) funding. H.R.3219, Department of Defense Appropriations Act, FY2018, Chemical and biological counter measures.
Issues related to climate change and emissions technologies.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Patient infusion therapy and reimbursement/policy issues related to non-opioid acute pain management. S.1738, Medicare Home Infusion Therapy Access Act of 2017. H.R.3178, Medicare Part B Improvement Act of 2017. H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act. S.3120, An original bill to amend titles XVIII and XIX of the Social Security Act to help end addictions and lessen substance abuse disorders, and for other purposes. H.R.6, SUPPORT for Patients and Communities Act.
Funding for aviation security and homeland security technologies, including Transportation Security Administration (TSA) funding and chemical and biological counter measures. S.3109/House, Department of Homeland Security Appropriations Act, 2019, Transportation Security Administration (TSA) funding. H.R.6157/S.3159, Department of Defense Appropriations Act, 2019, Chemical Biological Funding. H.R.5952/S.3072, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019, Opioid Funding. S.3158/House, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019, Reimbursement for Medical Devices.
Issues related to tort reform. H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017. H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017. H.R.3487, To amend section 1332 of title 28, United States Code, to provide that the requirement for diversity of citizenship jurisdiction is met if any one party to the case is diverse in citizenship from any one adverse party in the case.
Issues related to climate change and emissions technologies.
Tax issues affecting the industry, including repeal of the medical device excise tax. H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Issues related to climate change and emissions technologies.
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; H.R.3487, To amend section 1332 of title 28, United States Code, to provide that the requirement for diversity of citizenship jurisdiction is met if any one party to the case is diverse in citizenship from any one adverse party in the case; Issues related to tort reform.
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; H.R.3163, Medicare Part B Home Infusion Services Temporary Transitional Payment Act; issues related to patient infusion therapy. H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123); issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Reimbursement and policy issues related to non-opioid acute pain management.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax; H.R.195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes (P.L.115-120); H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123). Issues related to the repeal of the medical device excise tax; tax reform; international tax issues; manufacturing and taxes.
Filing targets: Army, Dept of (Other), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Reimbursement and policy issues related to non-opioid acute pain management.
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Medical device technology related to the opioid epidemic.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.
Reimbursement and policy issues related to non-opioid acute pain management.
Issues related to climate change and emissions technologies.
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Reimbursement and policy issues related to non-opioid acute pain management.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; H.R.1, Tax Cuts and Jobs Act (P.L.115-97); Issues related to the repeal of the medical device excise tax; tax reform; international tax issues; manufacturing and taxes.
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Reimbursement and policy issues related to non-opioid acute pain management.
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Issues related to climate change and emissions technologies.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Office of Policy Development, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Issues related to climate change and emissions technologies.
Implementation of 21st Century Cures Act (P.L.114-255); issues related to patient infusion therapy. H.R.2430, FDA Reauthorization Act of 2017; regulations related to Medical Device User Fee Amendments (MDUFA). H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
Implementation of 21st Century Cures Act (P.L.114-255); issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Conversations related to positive train control.
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.
Issues related to climate change and emissions technologies.
Filing targets: Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; P.L.114-255, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.
H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.
Conversations related to positive train control.
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
Filing targets: Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities.
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
Conversations related to positive train control.
Issues related to climate change and emissions technologies.
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Filing targets: Army, Dept of (Other), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Guard, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes.
Issues related to climate change and emissions technologies.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Guard, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Filing targets: Army, Dept of (Other), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Guard, SENATE, Transportation Security Administration (TSA), U.S. Customs & Border Protection